Anthony Edmund Reeve

Title: Anthony Edmund Reeve: Innovator in Colorectal Cancer Treatment

Introduction

Anthony Edmund Reeve is a notable inventor based in Dunedin, New Zealand. He has made significant contributions to the field of cancer treatment, particularly focusing on colorectal cancer. With a total of 3 patents, his work emphasizes the importance of genetic markers in predicting cancer prognosis.

Latest Patents

One of his latest patents involves methods for treating colorectal cancer using prognostic genetic markers. This invention relates to prognostic signatures, compositions, and methods for determining the prognosis of cancer in a patient, specifically for colorectal cancer. The invention utilizes genetic markers to predict the prognosis of cancer, allowing for a more tailored approach to treatment. It includes methods for predicting the likelihood of long-term survival of a cancer patient, determining treatment regimes, and preparing treatment modalities, along with kits and devices for implementing these methods.

Career Highlights

Throughout his career, Anthony has worked with companies such as Pacific Edge Limited and Pacific Edge Biotechnology Limited. His experience in these organizations has contributed to his expertise in the field of biotechnology and cancer research.

Collaborations

Anthony has collaborated with notable individuals in his field, including Hjalmar Nekarda and Jan Friederichs. These collaborations have further enhanced his research and development efforts in cancer treatment.

Conclusion

Anthony Edmund Reeve's innovative work in colorectal cancer treatment showcases the potential of genetic markers in improving patient outcomes. His contributions to the field are invaluable and continue to influence cancer research and treatment methodologies.